Could a simple Height-Based adjustment make tumor ablation safer?
NCT ID NCT07408375
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how to set the breathing machine (jet ventilator) during a procedure that destroys tumors with heat or cold. The goal is to find the best air pressure setting to keep patients breathing well while the doctor works precisely. About 560 adults having tumor ablation will be randomly assigned to one of four pressure settings, including one based on their height. The study will compare how often breathing problems occur with each setting.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 560 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Mar 2026
- Expected to finish
-
Mar 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age ≥ 18 years. * Patient undergoing thermal ablation of a solid tumor under HFJV. * Patient who has given their consent. * Patient covered by a social security scheme. Exclusion Criteria: * Patient under guardianship or curatorship. * Patient who does not understand French. * Pregnant and breastfeeding woman * Patient who has had a pneumonectomy * Patient requiring an endotracheal tube smaller than 6.5
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Solid tumor are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
7 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
CHU de Lyon
NOT_YET_RECRUITINGLyon, 69002, France
-
CHU de Nantes
RECRUITINGNantes, 44093, France
-
CHU de Nîmes
NOT_YET_RECRUITINGNîmes, 30900, France
-
CHU de Poitiers
NOT_YET_RECRUITINGPoitiers, 86000, France
-
Centre Léon Bérard
NOT_YET_RECRUITINGLyon, 69008, France
-
ICO Unicancer
NOT_YET_RECRUITINGSaint-Herblain, 44800, France
-
Institut Gustave Roussy
RECRUITINGVillejuif, 94800, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- First human test of BI 4060107 aims to find safe dose for Hard-to-Treat tumors
- Can a new drug shield kidneys from chemotherapy damage?
- Mining Responders' tumors for clues to a universal cancer therapy
- Proton boost radiotherapy aims to hit large tumors harder while sparing healthy tissue
- New antibody aims to preserve immune checkpoint while fighting cancer
- Engineered immune cells target two markers on Hard-to-Treat tumors